Omega Therapeutics, Inc.
OMGA · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$16 | -$16 | -$20 | -$20 |
| Dep. & Amort. | $3 | $1 | $2 | $2 |
| Deferred Tax | $0 | $0 | $0 | -$12 |
| Stock-Based Comp. | $2 | $1 | $3 | $2 |
| Change in WC | -$2 | $2 | $3 | -$1 |
| Other Non-Cash | $0 | $0 | $2 | $12 |
| Operating Cash Flow | -$14 | -$13 | -$12 | -$17 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $1 |
| Inv. Purchases | $0 | $0 | $0 | -$3 |
| Inv. Sales/Matur. | $0 | $0 | $5 | $3 |
| Other Inv. Act. | $0 | $0 | $5 | $3 |
| Investing Cash Flow | -$0 | -$0 | $4 | $2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | -$1 | -$1 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $2 |
| Financing Cash Flow | -$1 | -$1 | -$1 | $2 |
| Forex Effect | $0 | $0 | $0 | -$27 |
| Net Chg. in Cash | -$15 | -$14 | -$8 | -$13 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $46 | $60 | $68 | $82 |
| End Cash | $31 | $46 | $60 | $68 |
| Free Cash Flow | -$14 | -$13 | -$12 | -$18 |